|Institutional Source||Beutler Lab|
|Gene Name||5-hydroxytryptamine (serotonin) receptor 2A|
|Synonyms||Htr2, 5-HT2A receptor, Htr-2|
|Is this an essential gene?||Probably non essential (E-score: 0.071)|
|Stock #||R0117 (G1)|
|Chromosomal Location||74640840-74709494 bp(+) (GRCm38)|
|Type of Mutation||missense|
|DNA Base Change (assembly)||G to A at 74645093 bp|
|Amino Acid Change||Arginine to Histidine at position 173 (R173H)|
|Ref Sequence||ENSEMBL: ENSMUSP00000047774 (fasta)|
|Gene Model||predicted gene model for transcript(s): [ENSMUST00000036653]|
|Predicted Effect||probably damaging
AA Change: R173H
PolyPhen 2 Score 1.000 (Sensitivity: 0.00; Specificity: 1.00)
AA Change: R173H
|Meta Mutation Damage Score||0.9627|
|Coding Region Coverage||
|Validation Efficiency||95% (59/62)|
FUNCTION: [Summary is not available for the mouse gene. This summary is for the human ortholog.] This gene encodes one of the receptors for serotonin, a neurotransmitter with many roles. Mutations in this gene are associated with susceptibility to schizophrenia and obsessive-compulsive disorder, and are also associated with response to the antidepressant citalopram in patients with major depressive disorder (MDD). MDD patients who also have a mutation in intron 2 of this gene show a significantly reduced response to citalopram as this antidepressant downregulates expression of this gene. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Sep 2009]
PHENOTYPE: Mice homozygous for a knock-out allele show altered anxiety-related responses and increased vertical activity. Mice homozygous for a different knock-out allele exhibit abnormal enterocyte, Paneth cell and smooth muscle morphology. [provided by MGI curators]
|Allele List at MGI|
|Other mutations in this stock||
|Other mutations in Htr2a||
(F):5'- ACCTGTCCCCAAGTTGTAAGTCCTG -3'
(R):5'- GGGTCAAGTGCCCATATTCCTTAGC -3'
(F):5'- CCTGGGGTATAGATTACACGC -3'
(R):5'- CAGTCCAGTAACGATAGGTTTCG -3'